{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:01:14Z","timestamp":1792425674193,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01981-2","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:03:19Z","timestamp":1768197799000},"page":"2107-2129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fisetin-loaded Nanoemulsion and Fecal Microbiome Extract Enhance In Vitro Inhibition of Non-Small Cell Lung Cancer Progression"],"prefix":"10.1007","volume":"84","author":[{"given":"Adam","family":"Haysom-McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshav Raj","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Mehndiratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Zubbair","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Kokkinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prisca Deviani","family":"Pakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick E.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"De Rubis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"3","key":"1981_CR1","first-page":"209","volume":"71","author":"H. Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., & Jemal, A. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209\u2013249.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"1981_CR2","first-page":"45","volume":"25","author":"KC Thandra","year":"2021","unstructured":"Thandra, K. C., Barsouk, A., Saginala, K., Aluru, J. S., & Barsouk, A. (2021). Epidemiology of lung cancer. Contemp Oncol (Pozn), 25(1), 45\u201352.","journal-title":"Contemp Oncol (Pozn)"},{"issue":"18","key":"1981_CR3","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.3390\/cancers15184525","volume":"15","author":"S. A. Shehata","year":"2023","unstructured":"Shehata, S. A., Toraih, E. A., Ismail, E. A., Hagras, A. M., Elmorsy, E., & Fawzy, M. S. (2023). Vaping, environmental toxicants Exposure, and lung cancer risk. Cancers (Basel), 15(18), 4525.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1981_CR4","doi-asserted-by":"publisher","first-page":"Lmt46","DOI":"10.2217\/lmt-2020-0028","volume":"10","author":"M Soares","year":"2021","unstructured":"Soares, M., Antunes, L., Redondo, P., Borges, M., Hermans, R., Patel, D., et al. (2021). Treatment and outcomes for early non-small-cell lung cancer: A retrospective analysis of A Portuguese hospital database. Lung Cancer Management, 10(2), Lmt46.","journal-title":"Lung Cancer Management"},{"key":"1981_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijerph17196938","volume":"17","author":"A Lewandowska","year":"2020","unstructured":"Lewandowska, A., Rudzki, G., Lewandowski, T., Pr\u00f3chnicki, M., Rudzki, S., Laskowska, B., et al. (2020). Quality of life of cancer patients treated with chemotherapy. International Journal of Environmental Research and Public Health, 17, 19.","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"4","key":"1981_CR6","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4103\/CRST.CRST_87_20","volume":"3","author":"A Batra","year":"2020","unstructured":"Batra, A., Kalyani, C. V., & Rohilla, K. K. (2020). Incidence and severity of self-reported chemotherapy side-effects in patients with hematolymphoid malignancies: A cross-sectional study. Cancer Research Statistics and Treatment, 3(4), 736\u2013741.","journal-title":"Cancer Research Statistics and Treatment"},{"issue":"22","key":"1981_CR7","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJM199511303332202","volume":"333","author":"Early Breast Cancer Trialists Collaborative Group","year":"1995","unstructured":"Early Breast Cancer Trialists Collaborative Group. (1995). Effects of radiotherapy and surgery in early breast Cancer \u2014 An overview of the randomized trials. New England Journal of Medicine, 333(22), 1444\u20131456.","journal-title":"New England Journal of Medicine"},{"key":"1981_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.phytochem.2017.09.016","volume":"145","author":"R Mani","year":"2018","unstructured":"Mani, R., & Natesan, V. (2018). Chrysin: Sources, beneficial Pharmacological activities, and molecular mechanism of action. Phytochemistry, 145, 187\u2013196.","journal-title":"Phytochemistry"},{"key":"1981_CR9","doi-asserted-by":"publisher","first-page":"122255","DOI":"10.1016\/j.lfs.2023.122255","volume":"335","author":"H. C. Lo","year":"2023","unstructured":"Lo, H. C., Hua, W. J., Yeh, H., Lin, Z. H., Huang, L. C., & Ciou, Y. R. (2023). GMI, a ganoderma microsporum protein, abolishes focal adhesion network to reduce cell migration and metastasis of lung cancer. Life Sciences, 335, 122255.","journal-title":"Life Sciences"},{"issue":"7","key":"1981_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/ph17070921","volume":"17","author":"MA Danishuddin, Haque","year":"2024","unstructured":"Danishuddin, Haque, M. A., Malik, M. Z., Arya, R., Singh, P., Lee, J-S., et al. (2024). Unveiling the mechanisms underlying the immunotherapeutic potential of Gene\u2013miRNA and drugs in head and neck cancer. Pharmaceuticals, 17(7), 921.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"1981_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/1878-0261.13764","volume":"19","author":"A. Haysom-McDowell","year":"2024","unstructured":"Haysom-McDowell, A., Paudel, K. R., Yeung, S., Kokkinis, S., Sherkawi, E., & Chellappan, T., D. K (2024). Recent trends and therapeutic potential of phytoceutical-based nanoparticle delivery systems in mitigating non-small cell lung cancer. Molecular Oncology, 19(1), 15\u201336.","journal-title":"Molecular Oncology"},{"key":"1981_CR12","doi-asserted-by":"crossref","unstructured":"Kumar, S., Malik, M. Z., Chaturvedi, M., Mishra, M., Donato, M. D., Casamassimi, A. siRNA-based Therapeutic Candidate Targeting PRDM2 for Inhibition of Lung Cancer Progression. bioRxiv. 2025:2025.02. 06.636957.","DOI":"10.1101\/2025.02.06.636957"},{"key":"1981_CR13","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.jsbmb.2021.105954","volume":"213","author":"A Mihanfar","year":"2021","unstructured":"Mihanfar, A., Nouri, M., Roshangar, L., & Khadem-Ansari, M. H. (2021). Ameliorative effects of Fisetin in letrozole-induced rat model of polycystic ovary syndrome. Journal of Steroid Biochemistry and Molecular Biology, 213, 105954.","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"3","key":"1981_CR14","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s12035-016-9795-4","volume":"54","author":"A Ahmad","year":"2017","unstructured":"Ahmad, A., Ali, T., Park, H. Y., Badshah, H., Rehman, S. U., & Kim, M. O. (2017). Neuroprotective effect of Fisetin against Amyloid-Beta-Induced Cognitive\/Synaptic Dysfunction, Neuroinflammation, and neurodegeneration in adult mice. Molecular Neurobiology, 54(3), 2269\u20132285.","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"1981_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/nano11010059","volume":"11","author":"M Agarwal","year":"2020","unstructured":"Agarwal, M., Alam, M. R., Haider, M. K., Malik, M. Z., & Kim, D-K. (2020). Alzheimer\u2019s disease: An overview of major hypotheses and therapeutic options in nanotechnology. Nanomaterials, 11(1), 59.","journal-title":"Nanomaterials"},{"key":"1981_CR16","doi-asserted-by":"crossref","unstructured":"Alam, A., Tamkeen, N., Imam, N., Farooqui, A., Ahmed, M. M., & Tazyeen, S. (2018). Pharmacokinetic and molecular Docking studies of plant-derived natural compounds to exploring potential anti-Alzheimer activity. In D. Choudhary, M. Kumar, R. Prasad, & V. Kumar (Eds.), Silico approach for sustainable agriculture (pp. 217\u2013238). Springer.","DOI":"10.1007\/978-981-13-0347-0_13"},{"issue":"24","key":"1981_CR17","doi-asserted-by":"publisher","first-page":"9009","DOI":"10.3390\/molecules27249009","volume":"27","author":"A. H. Rahmani","year":"2022","unstructured":"Rahmani, A. H., Almatroudi, A., Allemailem, K. S., Khan, A. A., & Almatroodi, S. A. (2022). The potential role of Fisetin, a flavonoid in cancer prevention and treatment. Molecules, 27(24), 9009.","journal-title":"Molecules"},{"key":"1981_CR18","doi-asserted-by":"crossref","unstructured":"Bahman, F., Kochumon, S., Malik, M. Z., Akther, N., Jacob, S., Drobiova, H. (2025). H3K9 acetylation\u2013NF-\u03baB\u2013AP-1 nexus targeted by ITE limits TNF-\u03b1\u2013induced MMP-9 expression in monocytic cells. The Journal of Immunology, vkaf240.","DOI":"10.1093\/jimmun\/vkaf240"},{"key":"1981_CR19","doi-asserted-by":"publisher","first-page":"1128443","DOI":"10.3389\/fonc.2023.1128443","volume":"13","author":"Q Du","year":"2023","unstructured":"Du, Q., Liu, W., Mei, T., Wang, J., Qin, T., & Huang, D. (2023). Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis. Frontiers in Oncology, 13, 1128443.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"1981_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/BST20210751","volume":"50","author":"S Kumar","year":"2022","unstructured":"Kumar, S., Dorstyn, L., & Lim, Y. (2022). The role of caspases as executioners of apoptosis. Biochemical Society Transactions, 50(1), 33\u201345.","journal-title":"Biochemical Society Transactions"},{"issue":"3","key":"1981_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/jpm12030393","volume":"12","author":"N Bhattacharyya","year":"2022","unstructured":"Bhattacharyya, N., Gupta, S., Sharma, S., Soni, A., Bagabir, S. A., Bhattacharyya, M., et al. (2022). CDK1 and HSP90AA1 appear as the novel regulatory genes in non-small cell lung cancer: A bioinformatics approach. Journal of Personalized Medicine, 12(3), 393.","journal-title":"Journal of Personalized Medicine"},{"key":"1981_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms241814158","volume":"24","author":"J Szymczak","year":"2023","unstructured":"Szymczak, J., & Cielecka-Piontek, J. (2023). Fisetin-In search of better Bioavailability-From macro to nano modifications: A review. International Journal of Molecular Sciences, 24, 18.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"1981_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ijpharm.2012.02.025","volume":"427","author":"H Ragelle","year":"2012","unstructured":"Ragelle, H., Crauste-Manciet, S., Seguin, J., Brossard, D., Scherman, D., Arnaud, P., et al. (2012). Nanoemulsion formulation of Fisetin improves bioavailability and antitumour activity in mice. International Journal of Pharmaceutics, 427(2), 452\u2013459.","journal-title":"International Journal of Pharmaceutics"},{"key":"1981_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.colsurfb.2014.09.029","volume":"123","author":"JO Eloy","year":"2014","unstructured":"Eloy, J. O., Claro de Souza, M., Petrilli, R., Barcellos, J. P. A., Lee, R. J., & Marchetti, J. M. (2014). Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery. Colloids and Surfaces B: Biointerfaces, 123, 345\u2013363.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"1","key":"1981_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2013.02.032","volume":"334","author":"F Aqil","year":"2013","unstructured":"Aqil, F., Munagala, R., Jeyabalan, J., & Vadhanam, M. V. (2013). Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Letters, 334(1), 133\u2013141.","journal-title":"Cancer Letters"},{"key":"1981_CR26","first-page":"454","volume":"27","author":"M Safaya","year":"2020","unstructured":"Safaya, M., & Rotliwala, Y. C. (2020). Nanoemulsions: A review on low energy formulation methods, characterization, applications and optimization technique. Materials Today: Proceedings, 27, 454\u2013459.","journal-title":"Materials Today: Proceedings"},{"issue":"4","key":"1981_CR27","first-page":"1000","volume":"15","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., Shang, Z., Gao, C., Du, M., Xu, S., Song, H., et al. (2014). Nanoemulsion for solubilization, stabilization, and in vitro release of pterostilbene for oral delivery. An official Journal of the American Association of Pharmaceutical Scientists, 15(4), 1000\u20131008.","journal-title":"An official Journal of the American Association of Pharmaceutical Scientists"},{"key":"1981_CR28","doi-asserted-by":"publisher","first-page":"130218","DOI":"10.1016\/j.foodchem.2021.130218","volume":"362","author":"J Yi","year":"2021","unstructured":"Yi, J., Huang, H., Wen, Z., & Fan, Y. (2021). Fabrication of Chitosan-gallic acid conjugate for improvement of physicochemical stability of \u03b2-carotene nanoemulsion: Impact of Mw of Chitosan. Food Chemistry, 362, 130218.","journal-title":"Food Chemistry"},{"issue":"4","key":"1981_CR29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/nu15041019","volume":"15","author":"G. De Rubis","year":"2023","unstructured":"De Rubis, G., Paudel, K. R., Manandhar, B., Singh, S. K., Gupta, G., & Malik, R. (2023). Agarwood oil nanoemulsion attenuates cigarette Smoke-Induced inflammation and oxidative stress markers in BCi-NS1.1 airway epithelial cells. Nutrients, 15(4), 1019.","journal-title":"Nutrients"},{"key":"1981_CR30","doi-asserted-by":"publisher","first-page":"123720","DOI":"10.1016\/j.molliq.2023.123720","volume":"394","author":"Q Ye","year":"2024","unstructured":"Ye, Q., Kwon, S., Gu, Z., & Selomulya, C. (2024). Stable nanoemulsions for poorly soluble curcumin: From production to digestion response in vitro. Journal of Molecular Liquids, 394, 123720.","journal-title":"Journal of Molecular Liquids"},{"key":"1981_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.colsurfb.2019.06.006","volume":"181","author":"HY Xu","year":"2019","unstructured":"Xu, H. Y., Liu, C. S., Huang, C. L., Chen, L., Zheng, Y. R., Huang, S. H., et al. (2019). Nanoemulsion improves hypoglycemic efficacy of Berberine by overcoming its Gastrointestinal challenge. Colloids and Surfaces. B, Biointerfaces, 181, 927\u2013934.","journal-title":"Colloids and Surfaces. B, Biointerfaces"},{"key":"1981_CR32","first-page":"6640103","volume":"2023","author":"SS Preeti","year":"2023","unstructured":"Preeti, S. S., Malik, R., Bhatia, S., Al Harrasi, A., Rani, C., et al. (2023). Nanoemulsion: An emerging novel technology for improving the bioavailability of drugs. Scientifica (Cairo), 2023, 6640103.","journal-title":"Scientifica (Cairo)"},{"key":"1981_CR33","first-page":"1238","volume":"23","author":"AB Saeid","year":"2024","unstructured":"Saeid, A. B., Paudel, K. R., De Rubis, G., Mehndiratta, S., Kokkinis, S., Vishwas, S., et al. (2024). Fisetin-loaded nanoemulsion ameliorates lung cancer pathogenesis via downregulating cathepsin-B, galectin-3 and enolase in an in vitro setting. Excli J, 23, 1238\u20131244.","journal-title":"Excli J"},{"issue":"6","key":"1981_CR34","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1073\/pnas.0711891105","volume":"105","author":"FA Amaral","year":"2008","unstructured":"Amaral, F. A., Sachs, D., Costa, V. V., Fagundes, C. T., Cisalpino, D., Cunha, T. M., et al. (2008). Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A, 105(6), 2193\u20132197.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1981_CR35","doi-asserted-by":"publisher","first-page":"110231","DOI":"10.1016\/j.cbi.2022.110231","volume":"368","author":"S Ashique","year":"2022","unstructured":"Ashique, S., De Rubis, G., Sirohi, E., Mishra, N., Rihan, M., Garg, A., et al. (2022). Short chain fatty acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. Chemico-Biological Interactions, 368, 110231.","journal-title":"Chemico-Biological Interactions"},{"issue":"3","key":"1981_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/diseases9030060","volume":"9","author":"I. Balta","year":"2021","unstructured":"Balta, I., Butucel, E., Mohylyuk, V., Criste, A., Dezmirean, D. S., & Stef, L. (2021). Novel insights into the role of probiotics in respiratory Infections, Allergies, Cancer, and neurological abnormalities. Diseases, 9(3), 60.","journal-title":"Diseases"},{"issue":"2","key":"1981_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.gastro.2011.04.052","volume":"141","author":"P Bercik","year":"2011","unstructured":"Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., et al. (2011). The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology, 141(2), 599\u2013609. e1-3.","journal-title":"Gastroenterology"},{"issue":"10","key":"1981_CR38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","volume":"13","author":"JF Cryan","year":"2012","unstructured":"Cryan, J. F., & Dinan, T. G. (2012). Mind-altering microorganisms: The impact of The gut microbiota on brain and behaviour. Nature Reviews Neuroscience, 13(10), 701\u2013712.","journal-title":"Nature Reviews Neuroscience"},{"issue":"11","key":"1981_CR39","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.ajpath.2023.06.015","volume":"193","author":"J Chen","year":"2023","unstructured":"Chen, J., Chen, D. F., & Cho, K-S. (2023). The role of gut microbiota in glaucoma progression and other retinal diseases. The American Journal of Pathology, 193(11), 1662\u20131668.","journal-title":"The American Journal of Pathology"},{"issue":"10","key":"1981_CR40","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/antiox11101912","volume":"11","author":"S. Bakrim","year":"2022","unstructured":"Bakrim, S., Benkhaira, N., Bourais, I., Benali, T., Lee, L. H., & El Omari, N. (2022). Health benefits and Pharmacological properties of stigmasterol. Antioxidants, 11(10), 1912.","journal-title":"Antioxidants"},{"key":"1981_CR41","doi-asserted-by":"publisher","first-page":"101165","DOI":"10.1016\/j.mtchem.2022.101165","volume":"26","author":"L Corrie","year":"2022","unstructured":"Corrie, L., Gulati, M., Awasthi, A., Vishwas, S., Kaur, J., Khursheed, R., et al. (2022). Polysaccharide, fecal microbiota, and curcumin-based novel oral colon-targeted solid self-nanoemulsifying delivery system: formulation, characterization, and in-vitro anticancer evaluation. Materials Today Chemistry, 26, 101165.","journal-title":"Materials Today Chemistry"},{"key":"1981_CR42","doi-asserted-by":"publisher","first-page":"1091165","DOI":"10.3389\/fimmu.2023.1091165","volume":"14","author":"Y. Sun","year":"2023","unstructured":"Sun, Y., Wen, M., Liu, Y., Wang, Y., Jing, P., & Gu, Z. (2023). The human microbiome: A promising target for lung cancer treatment. Frontiers in Immunology, 14, 1091165.","journal-title":"Frontiers in Immunology"},{"key":"1981_CR43","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3389\/fmicb.2018.02897","volume":"9","author":"R Nagpal","year":"2018","unstructured":"Nagpal, R., Wang, S., Solberg Woods, L. C., Seshie, O., Chung, S. T., Shively, C. A., et al. (2018). Comparative Microbiome signatures and Short-Chain fatty acids in Mouse, Rat, Non-human Primate, and human feces. Frontiers in Microbiology, 9, 2897.","journal-title":"Frontiers in Microbiology"},{"key":"1981_CR44","doi-asserted-by":"publisher","first-page":"155387","DOI":"10.1016\/j.prp.2024.155387","volume":"260","author":"G De Rubis","year":"2024","unstructured":"De Rubis, G., Paudel, K. R., Vishwas, S., Kokkinis, S., Chellappan, D. K., Gupta, G., et al. (2024). Fecal Microbiome extract downregulates the expression of key proteins at the interface between airway remodelling and lung cancer pathogenesis in vitro. Pathology, Research and Practice, 260, 155387.","journal-title":"Pathology, Research and Practice"},{"issue":"4","key":"1981_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/medicina55040110","volume":"55","author":"R. Pezzani","year":"2019","unstructured":"Pezzani, R., Salehi, B., Vitalini, S., Iriti, M., Zu\u00f1iga, F. A., & Sharifi-Rad, J. (2019). Synergistic effects of plant derivatives and conventional chemotherapeutic agents: An update on the cancer perspective. Medicina, 55(4), 110.","journal-title":"Medicina"},{"issue":"2","key":"1981_CR46","doi-asserted-by":"publisher","first-page":"e86369","DOI":"10.1371\/journal.pone.0086369","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang, X., Beitler, J. J., Wang, H., Lee, M. J., Huang, W., Koenig, L., et al. (2014). Honokiol enhances Paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis. PLoS One, 9(2), e86369.","journal-title":"PLoS One"},{"key":"1981_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12935-016-0288-3","volume":"16","author":"A Klimaszewska-Wisniewska","year":"2016","unstructured":"Klimaszewska-Wisniewska, A., Halas-Wisniewska, M., Tadrowski, T., Gagat, M., Grzanka, D., & Grzanka, A. (2016). Paclitaxel and the dietary flavonoid fisetin: A synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells. Cancer Cell International, 16, 10.","journal-title":"Cancer Cell International"},{"key":"1981_CR48","doi-asserted-by":"publisher","first-page":"101252","DOI":"10.1016\/j.jddst.2019.101252","volume":"54","author":"R Kumar","year":"2019","unstructured":"Kumar, R., Khursheed, R., Kumar, R., Awasthi, A., Sharma, N., Khurana, S., et al. (2019). Self-nanoemulsifying drug delivery system of fisetin: Formulation, optimization, characterization and cytotoxicity assessment. Journal of Drug Delivery Science and Technology, 54, 101252.","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"2","key":"1981_CR49","first-page":"339","volume":"15","author":"MM Alvi","year":"2014","unstructured":"Alvi, M. M., & Chatterjee, P. (2014). A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug. An official Journal of the American Association of Pharmaceutical Scientists, 15(2), 339\u2013353.","journal-title":"An official Journal of the American Association of Pharmaceutical Scientists"},{"issue":"2","key":"1981_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/scipharm85020018","volume":"85","author":"H. Rachmawati","year":"2017","unstructured":"Rachmawati, H., Novel, M. A., Ayu, S., Berlian, G., Tandrasasmita, O. M., & Tjandrawinata, R. R. (2017). The in Vitro-In vivo safety confirmation of PEG-40 hydrogenated castor oil as a surfactant for oral nanoemulsion formulation. Scientia Pharmaceutica, 85(2), 18.","journal-title":"Scientia Pharmaceutica"},{"key":"1981_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.fct.2014.06.028","volume":"72","author":"DW Sullivan Jr","year":"2014","unstructured":"Sullivan, D. W. Jr., Gad, S. C., & Julien, M. (2014). A review of the nonclinical safety of Transcutol\u00ae, a highly purified form of diethylene glycol monoethyl ether (DEGEE) used as a pharmaceutical excipient. Food and Chemical Toxicology, 72, 40\u201350.","journal-title":"Food and Chemical Toxicology"},{"issue":"2","key":"1981_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2020034975","volume":"38","author":"ER Rani","year":"2021","unstructured":"Rani, E. R., & Radha, G. V. (2021). Insights into novel excipients of Self-Emulsifying drug delivery systems and their significance: An updated review. Critical Reviews in Therapeutic Drug Carrier Systems, 38(2), 27\u201374.","journal-title":"Critical Reviews in Therapeutic Drug Carrier Systems"},{"issue":"3","key":"1981_CR53","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/biom12030451","volume":"12","author":"AK Lalwani","year":"2022","unstructured":"Lalwani, A. K., Krishnan, K., Bagabir, S. A., Alkhanani, M. F., Almalki, A. H., Haque, S., et al. (2022). Network theoretical approach to explore factors affecting signal propagation and stability in dementia\u2019s Protein-Protein interaction network. Biomolecules, 12(3), 451.","journal-title":"Biomolecules"},{"issue":"12","key":"1981_CR54","doi-asserted-by":"publisher","first-page":"e08502","DOI":"10.1016\/j.heliyon.2021.e08502","volume":"7","author":"S Iqbal","year":"2021","unstructured":"Iqbal, S., Malik, M. Z., & Pal, D. (2021). Network-based identification of MiRNAs and transcription factors and in Silico drug screening targeting \u03b4-secretase involved in alzheimer\u2019s disease. Heliyon, 7(12), e08502.","journal-title":"Heliyon"},{"key":"1981_CR55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.sbi.2017.02.005","volume":"44","author":"Y Murakami","year":"2017","unstructured":"Murakami, Y., Tripathi, L. P., Prathipati, P., & Mizuguchi, K. (2017). Network analysis and in Silico prediction of protein\u2013protein interactions with applications in drug discovery. Current Opinion in Structural Biology, 44, 134\u2013142.","journal-title":"Current Opinion in Structural Biology"},{"issue":"11","key":"1981_CR56","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., et al. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498\u20132504.","journal-title":"Genome Research"},{"key":"1981_CR57","doi-asserted-by":"publisher","first-page":"177361","DOI":"10.1016\/j.ejphar.2025.177361","volume":"992","author":"S Singh","year":"2025","unstructured":"Singh, S., Singh, V., Singh, R., Gouri, V., Koch, B., & Samant, M. (2025). Synergistic combination of doxorubicin with Fisetin for the treatment of lymphoma. European Journal of Pharmacology, 992, 177361.","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"1981_CR58","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00280-010-1505-8","volume":"68","author":"YS Touil","year":"2011","unstructured":"Touil, Y. S., Seguin, J., Scherman, D., & Chabot, G. G. (2011). Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid Fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice. Cancer Chemotherapy and Pharmacology, 68(2), 445\u2013455.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"10","key":"1981_CR59","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.bcp.2012.07.012","volume":"84","author":"VM Adhami","year":"2012","unstructured":"Adhami, V. M., Syed, D. N., Khan, N., & Mukhtar, H. (2012). Dietary flavonoid fisetin: A novel dual inhibitor of PI3K\/Akt and mTOR for prostate cancer management. Biochemical Pharmacology, 84(10), 1277\u20131281.","journal-title":"Biochemical Pharmacology"},{"key":"1981_CR60","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.fct.2018.07.059","volume":"120","author":"C-F Tsai","year":"2018","unstructured":"Tsai, C-F., Chen, J-H., Chang, C-N., Lu, D-Y., Chang, P-C., Wang, S-L., et al. (2018). Fisetin inhibits cell migration via inducing HO-1 and reducing MMPs expression in breast cancer cell lines. Food and Chemical Toxicology, 120, 528\u2013535.","journal-title":"Food and Chemical Toxicology"},{"issue":"6","key":"1981_CR61","doi-asserted-by":"publisher","first-page":"e70309","DOI":"10.1002\/fsn3.70309","volume":"13","author":"J Gao","year":"2025","unstructured":"Gao, J., Song, Y., Luo, Z., Su, Z., Fu, C., Gao, A., et al. (2025). Study on the mechanism of Fisetin exerting Anti-Liver cancer effects by regulating neutrophil extracellular traps. Food Sci Nutr, 13(6), e70309.","journal-title":"Food Sci Nutr"},{"issue":"14","key":"1981_CR62","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.3390\/ijms26146945","volume":"26","author":"TR Kim","year":"2025","unstructured":"Kim, T. R., Son, B., Lee, C. G., & Park, H-O. (2025). Amphiregulin in fibrotic diseases and cancer. International Journal of Molecular Sciences, 26(14), 6945.","journal-title":"International Journal of Molecular Sciences"},{"key":"1981_CR63","doi-asserted-by":"publisher","first-page":"764151","DOI":"10.3389\/fcell.2021.764151","volume":"9","author":"X Guo","year":"2021","unstructured":"Guo, X., Chen, M., Cao, L., Hu, Y., Li, X., Zhang, Q., et al. (2021). Cancer-Associated fibroblasts promote migration and invasion of Non-Small cell lung cancer cells via miR-101-3p mediated VEGFA secretion and AKT\/eNOS pathway. Front Cell Dev Biol, 9, 764151.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1981_CR64","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-06-2149","volume":"67","author":"L Ying","year":"2007","unstructured":"Ying, L., & Hofseth, L. J. (2007). An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Research, 67(4), 1407\u20131410.","journal-title":"Cancer Research"},{"key":"1981_CR65","doi-asserted-by":"crossref","unstructured":"Jakobu\u0161i\u0107 Brala, C., Karkovi\u0107 Markovi\u0107, A., Kugi\u0107, A., Tori\u0107, J., & Barbari\u0107, M. (2023). Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies\u2014An Update Overview. Molecules, 28(9). Available from: https:\/\/mdpi-res.com\/d_attachment\/molecules\/molecules-28-03746\/article_deploy\/molecules-28-03746.pdf?version=1682524209","DOI":"10.3390\/molecules28093746"},{"key":"1981_CR66","doi-asserted-by":"crossref","unstructured":"Xiong, H-H., Lin, S-Y., Chen, L-L., Ouyang, K-H., & Wang, W-J. (2023). The Interaction between Flavonoids and Intestinal Microbes: A Review. Foods, 12(2). Available from: https:\/\/mdpi-res.com\/d_attachment\/foods\/foods-12-00320\/article_deploy\/foods-12-00320-v2.pdf?version=1673961253","DOI":"10.3390\/foods12020320"},{"issue":"10","key":"1981_CR67","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/s41416-022-01956-7","volume":"127","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Liu, X., Zeng, L., Zhao, X., Chen, Q., Pan, Y., et al. (2022). Exosomal protein angiopoietin-like 4 mediated radioresistance of lung cancer by inhibiting ferroptosis under hypoxic microenvironment. British Journal of Cancer, 127(10), 1760\u20131772.","journal-title":"British Journal of Cancer"},{"issue":"2","key":"1981_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3892\/ijo.2024.5715","volume":"66","author":"R. Liu","year":"2025","unstructured":"Liu, R., Fu, M., Chen, P., Liu, Y., Huang, W., & Sun, X. (2025). Emerging roles of angiopoietin\u2013like 4 in human tumors (Review). International Journal of Oncology, 66(2), 9.","journal-title":"International Journal of Oncology"},{"issue":"6","key":"1981_CR69","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.3892\/ol.2017.6048","volume":"13","author":"GS Shang","year":"2017","unstructured":"Shang, G. S., Liu, L., & Qin, Y. W. (2017). IL-6 and TNF-\u03b1 promote metastasis of lung cancer by inducing epithelial-mesenchymal transition. Oncol Lett, 13(6), 4657\u20134660.","journal-title":"Oncol Lett"},{"key":"1981_CR70","doi-asserted-by":"publisher","first-page":"153303382311552","DOI":"10.1177\/15330338231155284","volume":"22","author":"KM Hargadon","year":"2023","unstructured":"Hargadon, K. M., & Strong, E. W. (2023). The FOXC2 transcription factor: A master regulator of chemoresistance in cancer. Technology in Cancer Research & Treatment, 22, 15330338231155284.","journal-title":"Technology in Cancer Research & Treatment"},{"issue":"6","key":"1981_CR71","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00280-018-3697-2","volume":"82","author":"Y He","year":"2018","unstructured":"He, Y., Xie, H., Yu, P., Jiang, S., & Wei, L. (2018). FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells. Cancer Chemotherapy and Pharmacology, 82(6), 1049\u20131059.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"1","key":"1981_CR72","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12885-016-2169-5","volume":"16","author":"F-Y Niu","year":"2016","unstructured":"Niu, F-Y., Zhou, Q., Yang, J-J., Zhong, W-Z., Chen, Z-H., Deng, W., et al. (2016). Distribution and prognosis of uncommon metastases from non-small cell lung cancer. Bmc Cancer, 16(1), 149.","journal-title":"Bmc Cancer"},{"issue":"1","key":"1981_CR73","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","volume":"27","author":"K Ganesh","year":"2021","unstructured":"Ganesh, K., & Massagu\u00e9, J. (2021). Targeting metastatic cancer. Nature Medicine, 27(1), 34\u201344.","journal-title":"Nature Medicine"},{"issue":"6","key":"1981_CR74","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41385-022-00564-1","volume":"15","author":"TCA Hitch","year":"2022","unstructured":"Hitch, T. C. A., Hall, L. J., Walsh, S. K., Leventhal, G. E., Slack, E., de Wouters, T., et al. (2022). Microbiome-based interventions to modulate gut ecology and the immune system. Mucosal Immunology, 15(6), 1095\u20131113.","journal-title":"Mucosal Immunology"},{"key":"1981_CR75","doi-asserted-by":"publisher","first-page":"110231","DOI":"10.1016\/j.cbi.2022.110231","volume":"368","author":"S Ashique","year":"2022","unstructured":"Ashique, S., De Rubis, G., Sirohi, E., Mishra, N., Rihan, M., Garg, A., et al. (2022). Short chain fatty acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. Chem Biol Interact, 368, 110231.","journal-title":"Chem Biol Interact"},{"key":"1981_CR76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T-C Chou","year":"1984","unstructured":"Chou, T-C., & Talalay, P. (1984). Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27\u201355.","journal-title":"Advances in Enzyme Regulation"},{"issue":"5","key":"1981_CR77","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/1087057114521867","volume":"19","author":"W Zhao","year":"2014","unstructured":"Zhao, W., Sachsenmeier, K., Zhang, L., Sult, E., Hollingsworth, R. E., & Yang, H. (2014). A new bliss independence model to analyze drug combination data. SLAS Discovery, 19(5), 817\u2013821.","journal-title":"SLAS Discovery"},{"issue":"9","key":"1981_CR78","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1007\/s11033-023-08664-2","volume":"50","author":"M Jalalpour Choupanan","year":"2023","unstructured":"Jalalpour Choupanan, M., Shahbazi, S., & Reiisi, S. (2023). Naringenin in combination with quercetin\/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines. Molecular Biology Reports, 50(9), 7489\u20137500.","journal-title":"Molecular Biology Reports"},{"issue":"1","key":"1981_CR79","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/cbin.11942","volume":"47","author":"SS Hosseini","year":"2023","unstructured":"Hosseini, S. S., Ebrahimi, S. O., Haji Ghasem Kashani, M., & Reiisi, S. (2023). Study of Quercetin and Fisetin synergistic effect on breast cancer and potentially involved signaling pathways. Cell Biology International, 47(1), 98\u2013109.","journal-title":"Cell Biology International"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01981-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01981-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01981-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:35:18Z","timestamp":1781627718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01981-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":79,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1981"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01981-2","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"20 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}